Intense competition has led to continuous losses for Nanjing Panda Electronics, and jiegoutiaozheng of the Business structure still needs to break through. | Interpretations
1. Nanjing Panda Electronics expects a net income of approximately -0.22 billion yuan to -0.15 billion yuan in 2024, experiencing losses for two consecutive years, but the loss amount has narrowed compared to last year; 2. The company states that the Intelligent Manufacturing business and the power and communication business are facing intense competition in the current market, leading to a decrease in revenue and gross profit; 3. Despite the company's active adjustments to its business structure, the long transition period for market transformation has resulted in disappointing new customer expansion.
Only 6.6% away! Semiconductor Manufacturing International Corporation aims for a historical high, nearly 600 stocks have hit record highs this year, these stocks have created historical trading volumes.
① Today, Semiconductor Manufacturing International Corporation surged by 6.3%, with the intraday stock price reaching a new high in nearly two months, approaching the previously recorded all-time high. ② Currently, the financing balance of Semiconductor Manufacturing International Corporation remains at a historical high, but has recently decreased significantly, with a cumulative Shareholding of 2.1 billion yuan in the past month. ③ A total of over 590 stocks reached a new high this year today, with 43% of stocks also recording the highest trading volume for the year, among which 7 stocks simultaneously hit historical peak trading volumes.
Hainan's offshore duty-free sales are under pressure, with "duty-free king" experiencing a 77% drop in net income in the fourth quarter.
The city is further increasing duty-free options.
Sales growth of core varieties: REMEGEN's revenue in 2024 is expected to increase by more than 50% year-on-year, but it has not yet achieved profitability.
① The company has increased its R&D investment, while sales revenue of Tai Tasi Pu and Vidi Situt Monoclonal Antibody has grown rapidly, with the product gross margin continuing to rise and the sales expense ratio significantly decreasing. Therefore, it is expected that the company will report a net loss in 2024, showing a trend of reduced losses; ② The company's Phase III clinical trial for IgAN of Tai Tasi Pu in China has concluded, and data readout is expected in the first half of 2025.
BYD's overseas strategy: Brazil is a top priority, ASEAN is the present, Europe is the future.
Morgan Stanley stated that exports remain a key pillar for BYD to achieve sales growth in 2025, until its overseas production bases are fully operational. Amid escalating geopolitical tensions in other regions, ASEAN and the Americas will become major sales markets for BYD.
Cailian Press Autos Morning Report [January 16]
① The Ministry of Commerce: This week, detailed implementation rules for new purchase subsidies for mobile phones and other digital products will be issued successively; ② Guangdong: The production of New energy Fund vehicles will grow by 43% in 2024, accounting for a quarter of the national total; ③ Chongqing Changan Automobile: It will enter the Europe market in 2025;
bullrider_21 OP : BYD will delve into making humanoid robots.